 Circulating Tumor DNA
"Circulating Tumor DNA" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
DNA released from tumor cells that is found circulating in PLASMA; SERUM; or other BODY FLUIDS.
| Descriptor ID |
D000074141
|
| MeSH Number(s) |
D13.444.154.500 D13.444.308.425.500
|
| Concept/Terms |
Circulating Tumor DNA- Circulating Tumor DNA
- DNA, Circulating Tumor
- Tumor DNA, Circulating
- Cell-Free Tumor DNA
- Cell Free Tumor DNA
- DNA, Cell-Free Tumor
- Tumor DNA, Cell-Free
|
Below are MeSH descriptors whose meaning is more general than "Circulating Tumor DNA".
Below are MeSH descriptors whose meaning is more specific than "Circulating Tumor DNA".
This graph shows the total number of publications written about "Circulating Tumor DNA" by people in this website by year, and whether "Circulating Tumor DNA" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 2 | 0 | 2 | | 2017 | 1 | 1 | 2 | | 2018 | 4 | 0 | 4 | | 2020 | 3 | 0 | 3 | | 2021 | 2 | 0 | 2 | | 2022 | 9 | 0 | 9 | | 2023 | 2 | 0 | 2 | | 2024 | 1 | 1 | 2 | | 2025 | 3 | 2 | 5 | | 2026 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Circulating Tumor DNA" by people in Profiles.
-
Wong EYT, Damle SR, Shiu KK, Cohen SA, Lieu CH. Immunotherapy in Localized Colorectal Cancer: Current Practice and Future Directions. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e520600.
-
Stepan L, Ansari S, Abramson JS, Okal A, Dell'Aringa J, Thompson EG, Crotta A, Chow VA, Kamdar M, Solomon SR, Johnston PB, Glass B, Mutsaers P, Arnason J, Mielke S, Shadman M, Hernandez-Ilizaliturri F, Izutsu K, Bachanova V, Ibrahimi S, Chabon JJ, Kurtz DM, Alizadeh AA, Peiser L. Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy. J Clin Oncol. 2026 Jul; 44(19):1767-1773.
-
Geidel G, Fekade N, Raabe K, Smit DJ, Adam L, Heidrich I, Rünger A, Kött J, Zell T, Amaral T, Ascierto PA, Corrie P, Dummer R, Eggermont A, Guo J, Hassel JC, Jalving M, Johnson DB, Kandolf L, Kirkwood JM, Lebbé C, Lee R, Long GV, Lorigan P, Malvehy J, Mangana J, Mohr P, Patel SP, Rizos H, Robert C, Schadendorf D, Sondak VK, Svane IM, Wainstein A, Zager JS, Pantel K, Hauschild A, Gebhardt C. Translating ctDNA into cutaneous melanoma care: An international expert survey. Eur J Cancer. 2026 May 15; 239:116676.
-
Swanton C, Bryce A, Cohn AL, Margolis M, Hubbell E, Sagan A, Venn O, Seiden M. Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes Analysis. JCO Precis Oncol. 2026 Mar; 10(3):e2500725.
-
Collier AE, Hilz S, Chibly AM, Duan C, Pasquina LW, Sun X, Chavez-MacGregor M, Bardia A, Martín M, Lim E, Sohn J, Pérez-Moreno PD, Fernando TM, Moore HM. ctDNA and tumor-based biomarkers of giredestrant response in acelERA breast cancer. Nat Commun. 2026 Mar 12; 17(1).
-
Usami K, Mizuno T, Shirai R, Yoshioka T, Terashima K, Kiyotani C, Ogiwara H, Kato M. Detection of Tumor-Specific Variants in CSF of Children With Brain Tumors, Including Low-Grade and Cytology-Negative Cases. Pediatr Blood Cancer. 2026 Feb; 73(2):e70069.
-
Aaquist T, Henriksen TV, Mariager Jakobsen LL, Fristrup CW, Pfeiffer P, de Stricker K, Sparrelid E, Moro CF, Mortensen F, Knudsen AR, Hamilton-Dutoit S, Kleeff J, Mortensen MB, Andersen CL, Detlefsen S. Circulating tumour DNA as a prognostic tool for surgically treated pancreatic ductal adenocarcinoma. Hum Pathol. 2026 Feb; 168:106024.
-
Yee EJ, McCarter MD, Vogel JD, Schulick RD, Lieu C, Lentz RW. From Early Detection To Advanced Therapies: How Circulating Tumor DNA Is Transforming the Care of Colorectal Cancer. Curr Oncol Rep. 2025 Dec; 27(12):1464-1474.
-
Davies KD. Finding Rearrangements in the Cell-Free DNA Haystack. Clin Cancer Res. 2025 Jun 13; 31(12):2264-2266.
-
Bazhenova L, Hodgson JG, Camidge DR, Langer CJ, Huber RM, Kim DW, Reckamp KL, Ahn MJ, Tan DSW, Patel JD, Vincent S, Li C, Humphries MJ, Zhang P, Rivera VM, Gettinger S. Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation Status. Clin Lung Cancer. 2025 Nov; 26(7):e503-e513.e11.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|